A study by Virginia Commonwealth University Massey Cancer Center researchers published in today’s print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.
With personalized medicine, a shelved cancer drug could get another shot
February 8, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022